Gastrointestinal Stromal Tumor (GIST) Therapeutics Market

Future Market Insights

Key Insight

The gastrointestinal stromal tumor (gist) therapeutics market is projected to grow from USD 1,000.0 million in 2025 to USD 1,790.9 million by 2035, at a CAGR of 6.0%. Imatinib will dominate with a 41.7% market share, while targeted therapy will lead the therapy segment with a 56.3% share.

September 03, 2025

Anurag Sharma

288 Pages

Cite this Report

Gastrointestinal Stromal Tumor (GIST) Therapeutics Market

https://www.futuremarketinsights.com/reports/gastrointestinal-stromal-tumor-therapeutics-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Plexxikon Inc

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Gastrointestinal Stromal Tumor (GIST) Therapeutics Market

Key Players

Similar Industry Reports